Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-011871

Director acquired 2,280 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2024-06-13 Other acquisition 10b5-1 +134 $1.52 $204 241,411 D
Krogulski Kenneth Director 2024-06-14 Other acquisition 10b5-1 +256 $1.50 $384 241,667 D
Krogulski Kenneth Director 2024-06-17 Other acquisition 10b5-1 +204 $1.49 $304 241,871 D
Krogulski Kenneth Director 2024-06-18 Other acquisition 10b5-1 +204 $1.57 $320 242,075 D
Krogulski Kenneth Director 2024-06-20 Other acquisition 10b5-1 +204 $1.53 $312 242,279 D
Krogulski Kenneth Director 2024-06-21 Other acquisition 10b5-1 +204 $1.49 $304 242,483 D
Krogulski Kenneth Director 2024-06-24 Other acquisition 10b5-1 +218 $1.59 $347 242,701 D
Krogulski Kenneth Director 2024-06-25 Other acquisition 10b5-1 +218 $1.54 $336 242,919 D
Krogulski Kenneth Director 2024-06-26 Other acquisition 10b5-1 +218 $1.50 $327 243,137 D
Krogulski Kenneth Director 2024-06-27 Other acquisition 10b5-1 +218 $1.52 $331 243,355 D
Krogulski Kenneth Director 2024-06-28 Other acquisition 10b5-1 +202 $1.50 $303 243,557 D
Loading xslF345X05/marketforms-66488.xml…